Flammia RS, Leonardo C, Simone G. Re: Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1). Eur Urol 2025 Mar 10:S0302-2838(25)00132-0. doi: 10.1016/j.eururo.2025.
PMID: 40069076